Newsletters

The European Medicines Agency (EMA) publishes newsletters to provide updates on various topics to patients, healthcare professionals and the pharmaceutical industry.
HumanVeterinaryData on medicinesPharmacovigilanceSME

Also on this topic

Human medicines highlights

Human medicines highlights, published monthly, contains key information on human medicines and changes to regulatory processes in the past month. These highlights do not cover all EMA's activities in the area of human medicines.

Issues from May 2024 (Issue 180) onwards are available at the link below:

Use this link to receive Human Medicines Highlights by email:

Select the expandable panel below to access previous issues:

EU Regulatory Oncology Newsletter

Issues from October 2024 onwards are available at the link below: 

Use this link to receive the EU Regulatory Oncology Newsletter by email:

Small and Medium-sized Enterprises (SMEs) Highlights

Issues from February 2024 (Issue 61) onwards are available at the link below: 

Use this link to receive Small and Medium-sized Enterprises (SMEs) Highlights by email:

Select the expandable panel below to access previous issues:

Clinical Trials Highlights

Issues from July 2023 (Issue 15) onwards are available at the link below: 

Use this link to receive Clinical Trials Highlights by email:

Select the expandable panel below to access previous issues:

 

Veterinary Medicines Highlights

Issues from September 2023 (Issue 13) onwards are available at the link below: 

Use this link to receive Veterinary Medicines Highlights by email: 

Select the expandable panel below to access previous issues:

Big Data Highlights

Issues from June 2023 (Issue 6) onwards are available at the link below: 

Use this link to receive Big Data Highlights by email: 

Select the expandable panel below to access previous issues from 2022: 

 

 

Product Lifecycle Management Insights

Product Lifecycle Management Insights is available at the link below:

Use this link to receive Product Lifecycle Management Insights by email:

Share this page